What is the clinical evidence from this study?

Study design: Cohort. Population: End-stage renal disease on hemodialysis (n=86). Intervention: Long-term hemodialysis via arteriovenous access. Primary outcome: Prevalence of pulmonary hypertension (pulmonary artery systolic pressure >35 mmHg).

October 1, 2006Hemodialysis International

Among stable patients with end-stage renal disease receiving long-term hemodialysis via arteriovenous access, the prevalence of pulmonary hypertension was 26.74%.

View Full Paper

Ask AI

Bookmark

Population

86 stable patients with end-stage renal disease on hemodialysis via arteriovenous access for more than 12…

Design

Cross-sectional

Key result

Among stable patients with end-stage renal disease receiving long-term hemodialysis via arteriovenous access, the prevalence of pulmonary hypertension was 26.74%.

Authors

FTFaissal Tarrass MBM.C. Benjelloun GMG. Medkouri

Discussion

Member takes

Overview

Supports heightened vigilance for pulmonary hypertension in long-term hemodialysis; cross-sectional data leaves open causal drivers and outcome impact.

Study Design

Type

Cohort (n=86)

Structured PICO

Population

86 stable patients with end-stage renal disease receiving long-term hemodialysis via arteriovenous access for more than 12 months.

Outcome

Prevalence of pulmonary hypertension (defined as pulmonary artery systolic pressure >35 mmHg by Doppler echocardiography)surrogate

There is a high prevalence (26.74%) of pulmonary hypertension among patients with ESRD receiving long-term hemodialysis, which does not appear to be driven by vascular access, anemia, or secondary hyperparathyroidism.

Cite This Study

Tarrass et al. (2006) conducted a cohort in End-stage renal disease on hemodialysis (n=86). Long-term hemodialysis via arteriovenous access was evaluated on Prevalence of pulmonary hypertension (pulmonary artery systolic pressure >35 mmHg). Among stable patients with end-stage renal disease receiving long-term hemodialysis via arteriovenous access, the prevalence of pulmonary hypertension was 26.74%.

synapsesocial.com/papers/6aa0e4e1372f0d69599d2801 https://doi.org/10.1111/j.1542-4758.2006.00129.x

View Full Paper

Ask AI

Bookmark

October 1, 2006Hemodialysis International

Among stable patients with end-stage renal disease receiving long-term hemodialysis via arteriovenous access, the prevalence of pulmonary hypertension was 26.74%.

View Full Paper

Ask AI

Bookmark

Population

86 stable patients with end-stage renal disease on hemodialysis via arteriovenous access for more than 12…

Design

Cross-sectional

Key result

Among stable patients with end-stage renal disease receiving long-term hemodialysis via arteriovenous access, the prevalence of pulmonary hypertension was 26.74%.

Authors

FTFaissal Tarrass MBM.C. Benjelloun GMG. Medkouri

Discussion

Member takes

Overview

Supports heightened vigilance for pulmonary hypertension in long-term hemodialysis; cross-sectional data leaves open causal drivers and outcome impact.

Study Design

Type

Cohort (n=86)

Structured PICO

Population

86 stable patients with end-stage renal disease receiving long-term hemodialysis via arteriovenous access for more than 12 months.

Outcome

Prevalence of pulmonary hypertension (defined as pulmonary artery systolic pressure >35 mmHg by Doppler echocardiography)surrogate

Cite This Study

synapsesocial.com/papers/6aa0e4e1372f0d69599d2801 https://doi.org/10.1111/j.1542-4758.2006.00129.x

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark